Radioiodine Labelling Recombinant Human Plasminogen Kringle5 and Its Tumor Imaging

LI Biao,ZHAO Long,ZHANG Yi-fan,YIN Gui-zhi,ZHANG Zhi-yong,ZHU Cheng-mo
DOI: https://doi.org/10.3969/j.issn.1674-8115.2005.12.005
2005-01-01
Abstract:Objective To observe the feasibility of the recombinant human plasminogen kringle5(K5) labeled with radioiodine for tumor imaging. Methods Both ~(125)I-rhK5 and ~(131)I-rhK5 were labeled by Iodogen method. (Biodistribution) and tumor imaging were analysed in human lung cancer-bearing BALB/c nude mice. Results The labeling rate of ~(125)I-K5 and ~(131)I-K5 was 86% and 84%, and the radiochemical purity was 96% and 95% respectively.The ratios of tumor to muscle (T/NT) reached the highest level 4.94±0.89 at 12 h. Scintigraphic imaging from 1 to 5 h after ~(131)I-rhK5 injection showed that tumor could be clearly visualized at 3 h. Conclusion The labeling compound had high purity and stability.~(131)I-rhK5 could be used as a novel tumor imaging agent.
What problem does this paper attempt to address?